We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+15.58%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$3.42B
AUM Growth
+$102M
Cap. Flow
-$464M
Cap. Flow %
-13.58%
Top 10 Hldgs %
31.6%
Holding
114
New
35
Increased
21
Reduced
22
Closed
30

Top Buys

Rank Stock Value
1
UNP icon
Union Pacific
UNP
+$96M
2
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$87.8M
3
AAPL icon
Apple
AAPL
+$79.1M
4
BIIB icon
Biogen
BIIB
+$75.7M
5
NOW icon
ServiceNow
NOW
+$63M

Top Sells

Rank Stock Value
1
AET
Aetna Inc
AET
+$112M
2
AMAT icon
Applied Materials
AMAT
+$90.5M
3
ABBV icon
AbbVie
ABBV
+$61.7M
4
ALDR
Alder Biopharmaceuticals
ALDR
+$57.6M
5
MSFT icon
Microsoft
MSFT
+$52.5M

Sector Composition

Rank Sector Weight
1 Healthcare 36.89%
2 Technology 12.36%
3 Communication Services 7.79%
4 Consumer Discretionary 7.19%
5 Energy 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STWD icon
51
Starwood Property Trust
STWD
$6.15B
$21.9M 0.64%
+973,151
New +$21.5M
HCA icon
52
HCA Healthcare
HCA
$86.4B
$21M 0.61%
277,352
-365,521
-57% -$28M
SLCA
53
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$19.6M 0.58%
421,848
+39,507
+10% +$1.54M
TMUS icon
54
T-Mobile US
TMUS
$190B
$19.5M 0.57%
+418,116
New +$19.2M
MYOK
55
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$19.5M 0.57%
1,193,037
+354,227
+42% +$6.4M
ZLTQ
56
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$17.9M 0.52%
455,586
-148,756
-25% -$5.31M
BPMC
57
DELISTED
Blueprint Medicines
BPMC
$16.4M 0.48%
553,085
-1,093,431
-66% -$27.2M
VYGR icon
58
Voyager Therapeutics
VYGR
$187M
$16.3M 0.48%
1,357,973
+22,302
+2% +$302K
PEN icon
59
Penumbra
PEN
$12.6B
$15.8M 0.46%
207,465
+169,279
+443% +$11.7M
ICLR icon
60
Icon
ICLR
$13B
$15.1M 0.44%
+195,089
New +$14.7M
CNC icon
61
Centene
CNC
$31.6B
$13.6M 0.4%
+407,514
New +$14.2M
IONS icon
62
CALL
Ionis Pharmaceuticals
IONS
$9.25B
$12.8M 0.38%
+349,800
New +$10.9M
KURA icon
63
Kura Oncology
KURA
$901M
$12.5M 0.37%
2,007,642
+336,478
+20% +$1.7M
CSII
64
DELISTED
Cardiovascular Systems, Inc.
CSII
$11.9M 0.35%
+502,045
New +$11M
HOUS
65
DELISTED
Anywhere Real Estate
HOUS
$11.8M 0.34%
+454,543
New +$12.6M
REGN icon
66
PUT
Regeneron Pharmaceuticals
REGN
$69.9B
$11.2M 0.33%
27,800
-70,600
-72% -$28.3M
MDCO
67
CALL
DELISTED
Medicines Co
MDCO
$11.1M 0.32%
+293,900
New +$11.1M
VMC icon
68
Vulcan Materials
VMC
$36.9B
$10.8M 0.32%
95,398
-77,610
-45% -$9.15M
GRPN icon
69
Groupon
GRPN
$1.05B
$10M 0.29%
+97,196
New +$9.47M
NOVN
70
DELISTED
Novan, Inc. Common Stock
NOVN
$8.44M 0.25%
+41,801
New +$8.74M
HRC
71
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$7.76M 0.23%
+125,276
New +$7.06M
COLL icon
72
Collegium Pharmaceutical
COLL
$1.15B
$7.75M 0.23%
+402,446
New +$4.78M
ABBV icon
73
AbbVie
ABBV
$454B
$7.73M 0.23%
125,984
-953,642
-88% -$61.7M
ELGX
74
DELISTED
Endologix Inc
ELGX
$6.86M 0.2%
53,570
-102,324
-66% -$13.1M
SPNC
75
DELISTED
Spectranetics Corp
SPNC
$4.22M 0.12%
168,045
-89,974
-35% -$2.1M
1 2
3
4 5

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return

PFM Health Sciences's Q3 2016 Portfolio in Review

As of Q3 2016, PFM Health Sciences held 114 positions worth $3.42B, up 3.1% from $3.31B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

PFM Health Sciences withdrew a net $464M in Q3 2016, closing 30 positions and reducing 22 holdings. Its most notable exit was Aetna Inc, an estimated $112M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, down from 39% a quarter earlier, followed by Technology and Communication Services.

Against the trend, PFM Health Sciences opened a new position in Union Pacific worth $100M.

  • PFM Health Sciences's largest Q3 2016 buy was Union Pacific: 1,026,981 shares worth $100M.
  • PFM Health Sciences added most to Jazz Pharmaceuticals in Q3 2016, an estimated $87.8M increase.
  • PFM Health Sciences's biggest Q3 2016 reduction was AbbVie, cutting an estimated $61.7M.
  • PFM Health Sciences fully exited Aetna Inc in Q3 2016, selling an estimated $112M.
  • PFM Health Sciences's ten largest holdings make up 32% of its $3.42B portfolio in Q3 2016.
  • PFM Health Sciences opened 35 new positions and closed 30 in Q3 2016.
  • PFM Health Sciences's portfolio value rose 3.1% quarter-over-quarter to $3.42B.

Based on PFM Health Sciences's 13F filing for Q3 2016, filed 14 Nov 2016.